1. Home
  2. MNMD

MNMD

Mind Medicine (MindMed) Inc.

Logo Mind Medicine (MindMed) Inc.

Health Care

Pharmaceuticals and Biotechnology

Nasdaq

as 04-24-2024 3:21pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.

Founded: 2019 Country:
N/A
Employees: N/A City: NEW YORK
Market Cap: 696.5M IPO Year: N/A
Target Price: $30.17 AVG Volume (30 days): 2.3M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.44 EPS Growth: N/A
52 Week Low/High: $2.41 - $12.22 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: